×
About 3,870 results

ALLMedicine™ Cardiovascular Risk Management Center

Research & Reviews  160 results

Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Ma...
https://doi.org/10.1161/HYPERTENSIONAHA.122.19693
Hypertension (Dallas, Tex. : 1979); Picone DS, Stoneman E et. al.

Aug 2nd, 2022 - Accurate blood pressure (BP) measurement is critical for optimal cardiovascular risk management. Age-related trajectories for cuff-measured BP accelerate faster in women compared with men, but whether cuff BP represents the intraarterial (invasive...

Antiphospholipid Syndrome Treatment & Management
https://emedicine.medscape.com/article/333221-treatment

Jul 22nd, 2022 - Medical Care Patients with antiphospholipid syndrome (APS) may be evaluated in an outpatient setting. Inpatient evaluation is required if the patient presents with a significant clinical event. Patients with catastrophic APS (CAPS) require intense...

Cardiovascular risk management in patients with severe mental illness or taking antipsy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272927
The European Journal of General Practice; Jakobs K, Lautan L et. al.

Jul 8th, 2022 - Patients with severe mental illness (SMI) or receiving treatment with antipsychotics (APs) have an increased risk of cardiovascular disease. Cardiovascular risk management (CVRM) increasingly depends on general practitioners (GPs) because of the s...

Australian guideline on diagnosis and management of peripheral artery disease: part of ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254685
Journal of Foot and Ankle Research; Chuter V, Quigley F et. al.

Jul 6th, 2022 - Peripheral artery disease (PAD) is implicated in up to 50% of diabetes-related foot ulcers (DFU) and significantly contributes to morbidity and mortality in this population. An evidence-based guideline that is relevant to the national context incl...

Shared Care Follow-up After Chemotherapy for Testicular Cancer
https://clinicaltrials.gov/ct2/show/NCT01783145

May 18th, 2022 - Rationale: Since the introduction of cisplatin, metastatic testicular cancer (TC) has become a highly curable disease. Successfully treated TC patients have a small chance of a relapse. In case of a relapse, early treatment will improve outcome. T...

see more →

Drugs  1,334 results see all →

Clinicaltrials.gov  18 results

Shared Care Follow-up After Chemotherapy for Testicular Cancer
https://clinicaltrials.gov/ct2/show/NCT01783145

May 18th, 2022 - Rationale: Since the introduction of cisplatin, metastatic testicular cancer (TC) has become a highly curable disease. Successfully treated TC patients have a small chance of a relapse. In case of a relapse, early treatment will improve outcome. T...

SHOWME-PAD (Peripheral Artery Disease)
https://clinicaltrials.gov/ct2/show/NCT03190382

Apr 8th, 2022 - Peripheral arterial disease (PAD) is a burdensome condition that affects 10% of the population and increases to 15-20% among those ≥70 years. In PAD, the underlying pathophysiologic process, atherosclerosis, presents itself as blockages in patient...

Programme of Lifestyle Intervention in Families for Cardiovascular Risk Reduction
https://clinicaltrials.gov/ct2/show/NCT02771873

Jan 19th, 2021 - STUDY AIMS: AIM 1. To identify barriers to implementing an integrated cardiovascular risk management program in families of individuals with a positive history CHD. AIM 2. To assess the effectiveness of an integrated cardiovascular risk management...

Long Term Complications in Head and Neck Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT04257968

Feb 6th, 2020 - Problem: With increasing numbers of cancer survivors, strategies to prevent long-term complications in cancer patients become more important. Adolescent and Young Adult (AYA) Head and Neck Cancer survivors treated with radiotheray (RT) are prone t...

Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease
https://clinicaltrials.gov/ct2/show/NCT02110251

Jul 25th, 2019 - Patients with peripheral arterial disease with symptoms of critical ischemia or reduced tissue loss have a very high mortality and morbidity rate. So far, treatment strategies focused on the preservation of life and limb by an open surgical or end...

see more →

News  36 results

Study Estimates Prevalence of Metabolic Syndrome in Patients With Psoriatic Arthritis
https://www.medscape.com/viewarticle/969766

Mar 7th, 2022 - The prevalence of metabolic syndrome varies according to how it is defined, but approximately 30% of psoriatic arthritis (PsA) patients met the criteria in a cohort study of 724 individuals, as did approximately 23%-63% of patients across multiple...

One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis finds
https://www.mdedge.com/dermatology/article/252456/psoriatic-arthritis/one-third-psoriatic-arthritis-patients-could-have
Heidi Splete

Mar 4th, 2022 - The prevalence of metabolic syndrome varies according to how it is defined, but approximately 30% of psoriatic arthritis (PsA) patients met the criteria in a cohort study of 724 individuals, as did approximately 23%-63% of patients across multiple.

EULAR CVD Management Guidance Focuses on Gout, Lupus, Vasculitis
https://www.medscape.com/viewarticle/969087

Feb 24th, 2022 - New recommendations from the European Alliance of Associations for Rheumatology (EULAR) provide both broad and detailed advice for cardiovascular risk management in various rheumatic and musculoskeletal diseases (RMDs), many of which can lead to a...

Call for Tighter LDL Targets for Highest Risk Patients
https://www.medscape.com/viewarticle/962914

Nov 15th, 2021 - LONDON - Tighter low-density lipoprotein (LDL) targets, should be the aim in very high-risk patients, using a combination of therapies in a new era of ‘ones not twos’ (in terms of mmol/L), according to experts in lipid and cardiovascular risk mana...

Improvements in Cardiovascular Risk Management Needed for MPN
https://www.onclive.com/view/improvements-in-cardiovascular-risk-management-needed-for-mpn

Jun 11th, 2021 - Although cardiovascular health of patients with myeloproliferative neoplasms (MPN) was relatively good, an estimated 11% to 22% of patients were not prescribed appropriate medications for management of comorbidities associated with thrombotic risk...

see more →